C4 Therapeutics Raises $170 Million Financing to Bring Robust Pipeline of Protein Degraders to Clinical Proof-of-Concept and to Advance Proprietary Platform

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3hA4Cdm
via IFTTT